Delivery Order SPE2DB22D1017-SPE2DB25FYSED
- Not listed
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The Defense Logistics Agency awarded a $2,328.79 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and carries an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,891.24 on August 6, 2025, for the supply of Januvia 50 mg tablets (90-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $3,274.38. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a continuation of the company's pharmaceutical supply relationship with DLA. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $3,638.40 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (30-count units) under a firm fixed-price contract. The award was announced on May 30, 2025, with an ultimate completion date of June 2, 2025. This delivery order represents a non-set-aside, competitively awarded transaction executed through AmerisourceBergen's existing contract vehicle with the DLA. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $1,106.86. This non-set-aside delivery order is scheduled for completion by August 11, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located at the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Januvia 50 mg tablets (90-count packages) at a ceiling value of $1,925.58. This competitively awarded, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of September 12, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 50 mg tablets (90-count) valued at $1,316.00. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was awarded on a competitive, non-set-aside basis. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSEDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,274.38 to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Januvia 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and extending through December 2026. The IDC supports federal medical procurement for military and veteran healthcare systems, enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen fulfills various therapeutic needs through its established relationship with DLA, with this particular order contributing to ongoing medication supply requirements for federal military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/27/25 |